Prothrombin complex concentrates: preparation, properties, and clinical uses.
D000327:Adsorption; D000818:Animals; D001777:Blood Coagulation; D001779:Blood Coagulation Factors / Q000009:adverse effects / Q000627:therapeutic use; D002848:Chromatography, DEAE-Cellulose; D004285:Dogs; D005164:Factor IX / Q000627:therapeutic use; D015949:Factor IXa; D005168:Factor VII Deficiency / Q000188:drug therapy; D005171:Factor X Deficiency / Q000188:drug therapy; D005173:Factor XI Deficiency / Q000188:drug therapy; D006467:Hemophilia A / Q000188:drug therapy; D002836:Hemophilia B / Q000188:drug therapy; D006801:Humans; D007020:Hypoprothrombinemias / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy; D010314:Partial Thromboplastin Time; D011817:Rabbits; D013918:Thrombin Time; D013923:Thromboembolism / Q000139:chemically induced
D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D005164:Factor IX; D015949:Factor IXa